Kyo Diagnostics
ActivePersonalized healthcare business based on sensitivity testing on anticancer drugs for colorectal cancer.
What it does
"Kyo Diagnostics is a pioneering health and insurtech company specializing in personalized healthcare solutions. Utilizing advanced techniques to culture cancer stem cells from cancer tissue and Patient-Derived Spheroid Xenograft (PDSX) modeling technology, Kyo Diagnostics focuses on sensitivity testing for anticancer drugs, particularly for colorectal cancer. By offering tailored healthcare options based on individual patient needs and responses to treatment, Kyo Diagnostics aims to revolutionize cancer care and improve patient outcomes. The company's innovative approach to personalized medicine and drug testing showcases its commitment to advancing the field of oncology and providing cutting-edge solutions for patients and healthcare providers alike."
Next to it in Healthcare and bio · Personalized oncology drug sensitivity testing
- Notable LabsY Combinator W15
Personalized drug discovery for blood cancer.
- AnivancePlug and Play
Drug development solution, Paitent on chips
- 株式会社キュライオPlug and Play
Curreio is a biotechnology platform that provides contract business for structural analysis using cryo-electron microscopy.
- 株式会社EpigeneronPlug and Play
Epigeneron Inc. is a Drug discovery and detection of gene mutation Company.
- Guardant HealthPlug and Play
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs in oncology.
- インタープロテイン株式会社Plug and Play
Interprotein provides highly active modulators for protein-protein interaction (PPI) targets.
- Jiksak BioengineeringPlug and Play
Development of Human nervous system with iPS cells
- Metagen TherapeuticsPlug and Play
Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.